ADVATE has been shown to stop bleeds in everyday situations. You can count on ADVATE to work when you need it. In clinical trials most bleeds were managed with just 1 infusion of ADVATE.1 It works so you can get back to what's important in your life.
“I chose ADVATE because I can rely on it to manage the bleeds my son may experience.”
– Karen
____
Number of infusions per bleeding episode
ADVATE is based on the same full-length factor VIII molecule as RECOMBINATE [Antihemophilic Factor (Recombinant)]3
Indications:
ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] is indicated in hemophilia A (classical hemophilia) for the prevention and control of bleeding episodes and for perioperative management of patients with hemophilia A.
ADVATE is not indicated for the treatment of von Willebrand’s disease.
Important Safety Information:
Let your doctor know if you have had any previous allergic reactions to other factor VIII products or mouse or hamster proteins.
The most common related adverse reactions observed during the ADVATE clinical studies include: strange taste in mouth, headache, dizziness, and redness in the face.
There is a possibility that you can have an allergic reaction to ADVATE. Symptoms of an allergic reaction may include rash, hives, itching, tightness in throat or chest, difficulty breathing, feeling dizzy or light-headed, or a weak pulse. If you experience any of these symptoms, stop the infusion immediately and promptly contact your doctor.
Contact your doctor if you are not able to prevent or control bleeding episodes with your regular doses of factor VIII therapy.
